(Alliance News) - BP PLC on Monday announced it is teaming up with Tokyo-based JERA Co Inc to combine their offshore wind businesses to form a new joint venture.
Fidelity China noted the benchmark's rise was "mostly generated in September alone" following stimulus measures which included a rate cut by the People's Bank of China. According to the investor, ...
On the Beach Group PLC, up 3.6% at 242.98 pence, 12-month range 127.75p-244.00p. The beach holidays retailer climbs again, looking set to extend its winning streak to nine days. On Tuesday last week, ...
(Alliance News) - Inspecs Group PLC shares slumped on Monday as it warned its annual earnings will be down after recent weak trading.
"ISS states that Frasers has offered a superficial view of performance and no specific plans for change and the two Frasers candidates, Mike Ashley and Mike Lennon, have real conflicts of interest, ...
(Alliance News) - The UK Government will make a swift decision on whether to lift the ban on Islamist group Hayat Tahrir al-Sham, alias HTS, after it swept to power in Syria, ousting Bashar Assad's ...
Jefferies raises London Stock Exchange price target to 13,500 (12,500) pence - 'buy' Comments and questions to [email protected] Copyright 2024 Alliance News Ltd. All Rights Reserved.
(Alliance News) - IP Group PLC on Monday said it has agreed the sale of minority holdings in nine portfolio to a new fund managed by Lexham Capital Partners Ltd for around GBP15 million.
(Alliance News) - Domino's Pizza Group PLC on Monday said it had reached an agreement for a new five-year framework with its franchise partners as it said it will face a GBP3.0 million a year hit from ...
In addition, GSK said its Blenrep drug has been approved for priority review in China to treat sufferers of myeloma, a bone marrow cancer. The regulatory submission is supported by phase III ...
In Asia on Monday, the Shanghai Composite ended flat, with the closing bell coming too early to see a boost from the announcement. The Hang Seng in Hong, however, was 2.8% higher in late trade. In ...
"The breakthrough therapy designation granted by the FDA underscores the significant unmet need for new treatments for patients with previously treated EGFR-mutated non-small cell lung cancer who have ...